Skip to content
Screener

Gilead Sciences GILD Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

Incyte logo
IncyteINCY
$0.000.0%
Celcuity logo
CelcuityCELC
$0.000.0%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$0.000.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0.000.0%

Other financials

Income statement

See full
Revenue$7.8B+10.2%
Gross profit$6.2B+11.5%
Operating income-$10.4B-520%
Net income-$10.5B-636%
EPS (diluted)-$8.45-642%

Balance sheet

See full
Cash & equivalents$3.2B-38.2%
Total debt$26.2B+5.2%
Total equity$11.8B-39.9%
Total assets$49.4B-11.4%

Cash flow

See full
Operating cash flow$3.6B+332%
CapEx$140.0M+30.8%
Free cash flow$3.4B+377%

Valuation

See full
Market cap$162.47B+18.4%
Enterprise value$185.54B+18.2%
P/S5.3×+0.6×

Profitability

See full
Gross margin79.6%+1.1pp
Operating margin-8.2%-36.1pp
Net margin-10.6%-32.5pp
FCF margin42.5%+10.0pp

Returns & leverage

See full
Return on equity-20.6%-53.8pp
Debt / equity2.2×+1.0×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The source filing: Gilead Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000882095-26-000031
(in millions, except per share amounts)June 30, 2026December 31, 2025
Other long-term liabilities1,4901,165
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,241 shares issued and outstanding11
Additional paid-in capital9,5328,932
Accumulated other comprehensive income9539
Retained earnings2,20013,730

Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Gilead Sciences's preferred stock par value per share?
Gilead Sciences (GILD) reported preferred stock par value per share of $0.00 in Q2 2026.
How has Gilead Sciences's preferred stock par value per share changed year-over-year?
Gilead Sciences's preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What is the long-term trend for Gilead Sciences's preferred stock par value per share?
Over 5 years (2020 to 2025), Gilead Sciences's preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.

Ask your AI about Gilead Sciences's preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude